Neurocrine Biosciences chief legal officer sells $1.79m in stock

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Form 4 Arcus Biosciences Inc For: 13 July Hisse Senetleri 0 1
A Bernstein initiates Neurocrine stock with outperform rating on drug potential Hisse Senetleri 0 31
A Neurocrine presents two-year data on CAH treatment Crenessity Hisse Senetleri 0 15
A Oppenheimer raises Neurocrine Biosciences price target on acquisition Hisse Senetleri 0 51
A Neurocrine to buy Soleno Therapeutics for $2.9 billion Hisse Senetleri 0 26
A Cantor Fitzgerald raises Neurocrine Bio price target on Ingrezza outlook Hisse Senetleri 0 34
A Earnings call transcript: Neurocrine’s Q4 2025 beats forecasts, stock rises Hisse Senetleri 0 33
A Neurocrine Bio. stock price target raised to $198 by H.C. Wainwright Hisse Senetleri 0 39

Benzer konular

Üst